| Typicality: | 0.320 |
| Saliency: | 0.164 |
| 9–26 years of age | 4 | other |
| vaccine → be recommended for → male | 7 |
| vaccine → be recommended for → man | 3 |
| negative | neutral | positive |
| 0.145 | 0.704 | 0.151 |
| Raw frequency | 10 |
| Normalized frequency | 0.164 |
| Modifier score | 0.500 |
| Perplexity | 96.487 |